about
Cognitive neuropsychology of HIV-associated neurocognitive disordersEffects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy eraReplicative homeostasis II: influence of polymerase fidelity on RNA virus quasispecies biology: implications for immune recognition, viral autoimmunity and other "virus receptor" diseasesInteraction between Tat and Drugs of Abuse during HIV-1 Infection and Central Nervous System DiseaseInflammatory monocytes and the pathogenesis of viral encephalitisNeurologic complications of HIV-1 infection and its treatment in the era of antiretroviral therapyHIV Associated Neurocognitive DisordersVisualization and quantification of simian immunodeficiency virus-infected cells using non-invasive molecular imaging.HIV-1 Tat Activates Neuronal Ryanodine Receptors with Rapid Induction of the Unfolded Protein Response and Mitochondrial HyperpolarizationSynaptic Plasticity and Neurological Disorders in Neurotropic Viral InfectionsHIV and antiretroviral therapy in the brain: neuronal injury and repairSoluble and cell-associated insulin receptor dysfunction correlates with severity of HAND in HIV-infected womenAlarmins and central nervous system inflammation in HIV-associated neurological disorders.Over-reported peripheral neuropathy symptoms in a cohort of HIV infected and uninfected Rwandan women: the need for validated locally appropriate questionnaires.Rates of non-confounded HIV-associated neurocognitive disorders in men initiating combination antiretroviral therapy during primary infection.The National NeuroAIDS Tissue Consortium brain gene array: two types of HIV-associated neurocognitive impairment.Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients.Proteomic analyses of monocyte-derived macrophages infected with human immunodeficiency virus type 1 primary isolates from Hispanic women with and without cognitive impairment.Synaptic proteins linked to HIV-1 infection and immunoproteasome induction: proteomic analysis of human synaptosomes.Proton magnetic resonance spectroscopy reveals neuroprotection by oral minocycline in a nonhuman primate model of accelerated NeuroAIDSNeurologic presentations of AIDS.Screening for HIV-associated peripheral neuropathy in resource-limited settingsGene expression patterns associated with neurological disease in human HIV infectionMorphine increases hippocampal viral load and suppresses frontal lobe CCL5 expression in the LP-BM5 AIDS modelNuclear factor-kappa B family member RelB inhibits human immunodeficiency virus-1 Tat-induced tumor necrosis factor-alpha production.Neurocognitive effects of HIV, hepatitis C, and substance use historyNanomedicine in the diagnosis and therapy of neurodegenerative disorders.Pathogenesis of HIV in the central nervous systemProgesterone protects normative anxiety-like responding among ovariectomized female mice that conditionally express the HIV-1 regulatory protein, Tat, in the CNS.Neurotoxicity of human immunodeficiency virus-1: viral proteins and axonal transportIbudilast, a pharmacologic phosphodiesterase inhibitor, prevents human immunodeficiency virus-1 Tat-mediated activation of microglial cellsHIV and SIV induce alterations in CNS CaMKII expression and activation: a potential mechanism for cognitive impairment.Mechanisms of HIV-tat-induced phosphorylation of N-methyl-D-aspartate receptor subunit 2A in human primary neurons: implications for neuroAIDS pathogenesisGene expression changes consistent with neuroAIDS and impaired working memory in HIV-1 transgenic rats.Curcumin ameliorates hippocampal neuron damage induced by human immunodeficiency virus-1The cerebrospinal fluid HIV risk score for assessing central nervous system activity in persons with HIV.Significant effects of antiretroviral therapy on global gene expression in brain tissues of patients with HIV-1-associated neurocognitive disordersExploring Substance Use and HIV Treatment Factors Associated with Neurocognitive Impairment among People Living with HIV/AIDS.HIV-associated neurocognitive disorder: pathogenesis and therapeutic opportunities.Single genome analysis reveals genetic characteristics of Neuroadaptation across HIV-1 envelope.
P2860
Q22252615-95313296-738C-45B9-8B8A-9CF0CD4D7DA2Q24632654-D37CA410-2483-4A75-96F9-E0474345FEA1Q24814157-48707B62-C111-41E0-A5B8-1E1443C04F97Q26770397-E9CBC2EF-0D66-4E23-AA72-A4A19925392DQ26861256-7FDA4E2C-A4CD-41FC-A8BB-681DCF3E35E8Q27000422-8FC6735C-18F2-43D6-BF4D-38541D141CA4Q27023968-7D7BEFF5-6D71-42CA-8B46-6709260A37C7Q27323244-3F7E6B4A-5A11-41C2-A685-B47F22D9C1F4Q27487322-7A7050EF-EED5-4458-A9E5-46009B727688Q28088477-E60CF5C1-4FC9-4809-9F6D-1DFD10F56F89Q28279808-CE4B7511-7464-4272-B5DC-1BCE0D157741Q28729739-34212749-BCAE-49F4-A047-F39544BFF611Q30241037-F8BFB901-F285-40CC-B9FF-466EADF34E42Q30390516-8EEDC462-F28B-4904-9EA7-9166F48CFCE4Q30690955-C48E4B66-0159-42F3-8A77-474981B59729Q31104394-98E2539E-80CF-4CBB-8131-0D34469071A8Q33346244-45A40EED-0D2B-4522-86B9-909C1649FA47Q33396476-8892EBC2-2939-4F5B-BD3C-89470356F98FQ33495226-C45FA35B-E67F-4649-8CD9-6F1A9A5EB4A6Q33580220-B33B8414-FE35-439F-BDB9-6177EE360158Q33590337-6BF3CA15-31A9-46B5-9DB7-436C24E8B071Q33603950-20062CA2-946B-407F-9B44-C683D042A612Q33605737-56B6D529-319B-4B63-9D28-09B5BC6E8787Q33632272-B464F377-CFB1-4E04-9565-8664592CEE1DQ33649838-BF2B0D41-8961-42A4-878A-6F2833F06B17Q33652957-9F4B9B66-D13C-457A-BCD3-C121953A9C4EQ33726019-DD04B224-21B9-4288-BDDA-4BA4A543E833Q33781978-BC72C183-FDAD-4DA4-A955-D0EA74703C19Q33795961-D20A192D-73C7-442A-8910-0FA4E9DE6827Q33870898-CF2AAE12-BA59-48FC-95D1-A3FA3B495638Q33873538-7ADDD43A-B86D-42E3-BB97-3F50551D38FEQ33882450-0B64B420-6149-4526-A216-4357CB77F2C0Q33882476-37B0508D-7555-4FA3-98B3-26BF6E029ACCQ33936233-D60C8F15-1540-425A-B290-46C60B4666EAQ33937629-07FB704E-8044-4170-A1FB-F017EE451114Q33938797-0C5A2794-4252-45F6-9C62-4DC0ACF53668Q34016222-D5686362-6C47-40CB-9D0E-AA1C945CE9C0Q34024194-27F27136-C21A-478A-8790-6C64E5B83543Q34037622-6002BD60-E004-4E36-92D5-6817DA1C5688Q34091371-3F941114-80F4-4AA7-921F-6E1F3EEF565F
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
HIV dementia: an evolving disease.
@ast
HIV dementia: an evolving disease.
@en
type
label
HIV dementia: an evolving disease.
@ast
HIV dementia: an evolving disease.
@en
prefLabel
HIV dementia: an evolving disease.
@ast
HIV dementia: an evolving disease.
@en
P1476
HIV dementia: an evolving disease.
@en
P2093
Justin C McArthur
P356
10.1016/J.JNEUROIM.2004.08.042
P577
2004-12-01T00:00:00Z